Adaptimmune today announces the release of preliminary results from an early phase clinical study using patients' own T cells that have been genetically altered to attack multiple myeloma cells.
http://www.biospace.com/news_story.aspx?StoryID=282010&full=1
http://www.biospace.com/news_story.aspx?StoryID=282010&full=1
No comments:
Post a Comment